PON1 and hypothyroidism: Similarly, Baskol et al. [34] reported the therapeutic benefit of levothyroxine in increasing SOD and PON 1 serum levels in hypothyroidism, and research has also shown that T3 administration leads to transcriptional upregulation of enzymatic antioxidants such as superoxide dismutase and catalase in hypothyroid rats [49].